Triangle Securities Wealth Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Triangle Securities Wealth Management's AGN Position: Q4 2017 in Review
Triangle Securities Wealth Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 2,173 shares — an estimated $445K sold.
Triangle Securities Wealth Management first reported a position in AGN in Q2 2016 and held it in 6 quarters. The position peaked at $542K in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.
- Triangle Securities Wealth Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
- Triangle Securities Wealth Management sold 2,173 Allergan plc shares in Q4 2017, an estimated $445K.
- Triangle Securities Wealth Management first reported a position in Allergan plc in Q2 2016 and held it in 6 quarters.
- Triangle Securities Wealth Management's Allergan plc position peaked at $542K in Q2 2017.
- 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.
Based on Triangle Securities Wealth Management's 13F filing for Q4 2017, filed 10 Jan 2018.